NEWS FOCUS

The ‘world's-first’ vaccine against vomiting bug norovirus is set to be trialled in the UK.
Called Nova 301, the study is part of the 10-year Moderna-UK Strategic Partnership and involves a collaboration between the National Institute for Health and Care Research, the Department of Health and Social Care, the UK Health Security Agency and the pharmaceutical company Moderna, which is producing the vaccine.
Dr Patrick Moore, chief investigator of the study and National Institute for Health and Care Research director in the Southwest, said there were currently ‘no approved vaccines for norovirus anywhere in the world’ and the only treatment available for people with serious illness in hospital is intravenous fluids. ‘We hope that the jab could bring huge health and economic benefits.’
Norovirus is known as the winter vomiting bug and is highly transmissible. It causes vomiting and diarrhoea, usually for two to three days and can affect people of all ages.
According to Dr Moore, ‘about one in five cases of gastroenteritis are caused by norovirus – that's about four million cases annually in the UK and about 685 million globally.’
Register now to continue reading
Thank you for visiting Practice Nursing and reading some of our peer-reviewed resources for general practice nurses. To read more, please register today. You’ll enjoy the following great benefits:
What's included
-
Limited access to clinical or professional articles
-
New content and clinical newsletter updates each month